Trials / Completed
CompletedNCT03128710
Prostate Cancer Survey
Identifying Patient-relevant Adverse Events Following Prostate Radiotherapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 224 (actual)
- Sponsor
- University of Maryland, Baltimore · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
There have been calls from patients, payers, healthcare providers, and policy makers for an evaluation of newer, high-cost radiation technologies compared to conventional forms of radiation therapy. National attention has focused on the use of intensity modulated radiation therapy (IMRT) into routine daily clinical practice for prostate cancer. The goal of the present study is to determine whether the type of radiation treatment received by the patients can result in a reduction in patient-relevant side effects following prostate irradiation. The analysis will be performed by obtaining patient answered surveys looking at side effects.
Conditions
Timeline
- Start date
- 2017-03-15
- Primary completion
- 2018-02-15
- Completion
- 2018-02-15
- First posted
- 2017-04-25
- Last updated
- 2024-11-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03128710. Inclusion in this directory is not an endorsement.